Butovsky; Oleg

Patent Applications and Registrations

Patent applications and USPTO patent grants for Butovsky; Oleg.The latest application filed is for "methods of suppressing microglial activation".

Company Profile

3.6.16

Butovsky; Oleg - Boston MA
BUTOVSKY; Oleg - Needham MA
Butovsky; Oleg - Beer Sheva IL
Butovsky; Oleg - Sheva IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Suppressing Microglial Activation App 20200165338 - Butovsky; Oleg ; et al.	2020-05-28
Micrornas In Neurodegenerative Disorders App 20190276892 - Weiner; Howard ; et al.	2019-09-12
Micrornas in neurodegenerative disorders Grant 10,184,151 - Weiner , et al. Ja	2019-01-22
Mir-155 Inhibitors For Treating Amyotrophic Lateral Sclerosis (als) App 20180161357 - JACKSON; Aimee ; et al.	2018-06-14
Targeting Apolipoprotein E (APOE) in Neurologic Disease App 20180155414 - Butovsky; Oleg ; et al.	2018-06-07
Micrornas In Neurodegenerative Disorders App 20180023142 - Weiner; Howard ; et al.	2018-01-25
Targeting Apolipoprotein E (APOE) in Neurologic Disease App 20170334977 - Butovsky; Oleg ; et al.	2017-11-23
Vaccine and method for treatment of neurodegenerative diseases Grant 9,517,256 - Eisenbach-Schwartz , et al. December 13, 2	2016-12-13
Method of treatment of age-related macular degeneration Grant 9,089,509 - Eisenbach-Schwartz , et al. July 28, 2	2015-07-28
Vaccine and method for treatment of neurodegenerative diseases Grant 8,828,404 - Eisenbach-Schwartz , et al. September 9, 2	2014-09-09
Micrornas In Neurodegenerative Disorders App 20140235697 - Weiner; Howard ; et al.	2014-08-21
Methods of Treating Inflammatory Diseases by Targeting the Chemoattractant Cytokine Receptor 2 (CCR2) or Chemokine (C-C motif) Ligand 2 (CCL2) App 20140178367 - Weiner; Howard ; et al.	2014-06-26
Vaccine And Method For Treatment Of Neurodegenerative Diseases App 20140134196 - EISENBACH-SCHWARTZ; Michal ; et al.	2014-05-15
Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1 App 20120135016 - Eisenbach-Schwartz; Michal ; et al.	2012-05-31
Vaccine And Method For Treatment Of Neurodegenerative Diseases App 20110206706 - Eisenbach-Schwartz; Michal ; et al.	2011-08-25
Method of treatment of age-related macular degeneration App 20100135953 - Eisenbach-Schwartz; Michal ; et al.	2010-06-03
Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1 App 20090191173 - Eisenbach-Schwartz; Michal ; et al.	2009-07-30
Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis App 20090010873 - Eisenbach-Schwartz; Michal ; et al.	2009-01-08
Vaccine And Method For Treatment Of Neurodegenerative Diseases App 20080085269 - Eisenbach-Schwartz; Michal ; et al.	2008-04-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.